Publications
- Structure-Guided Design of N-Methylpropargylamino- Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer's Disease2023 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Faculty of Pharmacy in Hradec Králové, Faculty of Science
- Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico study2021 | Faculty of Pharmacy in Hradec Králové
- Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties2021 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- UHPLC-Orbitrap study of the first phase tacrine in vitro metabolites and related Alzheimer's drug candidates using human liver microsomes2023 | Faculty of Pharmacy in Hradec Králové
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Faculty of Pharmacy in Hradec Králové
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Faculty of Pharmacy in Hradec Králové
- An efficient synthesis and cytotoxic profile of D-ribo- phytosphingosine and its analogues2023 | Publication without faculty affiliation
- BODIPY-labelled acetylcholinesterase reactivators can be encapsulated into ferritin nanovehicles for enhanced bioavailability in the CNS2023 | Publication without faculty affiliation
Loading network view...